ValiRx (LON:VAL) Trading Down 9% – What’s Next?

ValiRx plc (LON:VAL)’s stock price dropped 9% during trading on Wednesday . The company traded as low as GBX 0.13 and last traded at GBX 0.13. 2,186,069 shares changed hands during trading, a decline of 79% from the average session volume of 10,512,327 shares. The stock had previously closed at GBX 0.14.

ValiRx Stock Down 7.1%

The firm has a market capitalization of £1.72 million, a price-to-earnings ratio of -0.24 and a beta of 0.59. The stock has a fifty day moving average of GBX 0.16 and a two-hundred day moving average of GBX 0.22. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.62 and a quick ratio of 1.27.

ValiRx (LON:VAL) last announced its earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share (EPS) for the quarter. The company had revenue of GBX 3 million for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%. Sell-side analysts anticipate that ValiRx plc will post -1.74 earnings per share for the current year.

About ValiRx

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.